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Introduction
A hallmark of the differentiation of transporting epithelia is   
the generation of a luminal or apical domain (Rodriguez-Boulan 
and Nelson, 1989; O’Brien et al., 2002). Nonstratified epithelia 
differ in the position of their luminal domain: columnar epithe-
lia (e.g., kidney, intestine, or pancreas), display their lumina at 
the cell apex, separated by tight junctions from lateral domains 
enriched in cell–cell adhesion molecules, and opposite to basal 
domains enriched in receptors for the ECM. In contrast, hepatic 
epithelial cells establish their lumina, the bile canaliculi (BC), 
at sites of intercellular contact, separated by tight junctions from 
basolateral domains specialized for cell–cell interactions and 
exchange with the bloodstream (sinusoidal membranes).
In columnar epithelia, apical polarity determinants such 
as the Crumbs/Pals/Patj and the Cdc42–Par6–aPKC signaling 
complexes and Rab-GTPases, such as Rab8a and 11a that con-
nect them to the polarized exocytic machinery, are essential for 
the formation of a luminal domain in vivo and in culture   
(Martin-Belmonte et al., 2007; Wang and Margolis, 2007; Bryant 
et al., 2010). Likewise, E-cadherin–mediated signaling provides 
a cue for lumen formation, per se (Vega-Salas et al., 1988). 
Cell–ECM signaling, on the other hand, appears to determine 
the orientation of polarity rather than cell polarity itself (Bryant 
and Mostov, 2008). Thus, when cultured in the absence of 
neighboring cells, kidney-derived MDCK cells restrict luminal 
markers to the free cell surface (Vega-Salas et al., 1987) When 
suspended in collagen I gels, MDCK cells proliferate to form 
hollow cysts. 1-Integrin orients the apical surface to face the 
cyst lumen by activating Rac1 and inhibiting rhoA and its tar-
gets ROCK and myosin II. Rac1 inside-out signaling in turn   
organizes laminin into a basal lamina that is essential for lumen 
orientation (O’Brien et al., 2001; Yu et al., 2005, 2008). Hepato-
cytes on the other hand are surrounded by ECM components, 
but unlike columnar epithelia, do not organize these compo-
nents into a basal lamina. Indeed, basement membrane deposi-
tion, as it occurs in pathological situations such as cholestasis, 
leads to loss of hepatocyte polarity (Martinez-Hernandez and 
Amenta, 1993). In primary hepatocyte cultures, BC form only 
on moderately adhesive surfaces or in ECM sandwich cultures 
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formation in 2D cultures. The ECM-signaling phenotype was 
accompanied by a switch from apical to lateral lumen polarity, 
suggesting that cell adhesion signaling constitutes the under-
lying mechanism for the lumen polarity phenotype observed 
under both experimental conditions.
Results
Par1b inhibits cell spreading, laminin 
assembly, and stress fiber formation
MDCK  cells  overexpressing  Par1b  under  a  doxycycline 
(dox)-dependent  promoter  (Par1b-MDCK  Tet-Off;  Cohen   
et al., 2004) form tighter colonies and lateral lumina, whereas 
Par1b-depleted monolayers are less compact than controls 
(Fig. 1 A, left, “on plastic”). These observations prompted   
us to analyze whether Par1b levels affect the kinetics and ex-
tent of cell spreading. Dox-regulated expression of a Par1b 
shRNAmir construct (Par1b-KD-MDCK Tet-Off; see Par1b 
depletion  in  Fig.  2  D)  promoted  cell  spreading  between   
30 and 120 min after plating (Fig. 1 B, left), whereas dox- 
dependent overexpression of the kinase inhibited spreading 
on collagen I (Fig. 1 B, right).
Live cell analysis of newly plated Par1b-MDCK or Par1b-
KD-MDCK cells cotransfected with mRFP-actin revealed that 
Par1b  overexpression  disrupted  the  continuous  lamellipodia 
skirt surrounding the cell periphery in controls and reduced the 
appearance of circumferential stress fibers and thin bundles of 
actin projecting radially away from the cell edge. Instead, indi-
vidual, large and dynamic lamella emerged from the cell body 
in Par1b-MDCK cells (Fig. 1, C and F, Par1b; and Videos 1 and 5). 
Par1b-GFP  colocalized  with  F-actin–rich  regions  at  the  tips   
of those dynamic cell protrusions and filopodia (Fig. 1 F and 
Video 5). We also performed live cell analysis of the focal adhe-
sion (FA)–associated protein paxillin-mCherry (Schaller, 2001). 
Freshly plated GFP-expressing cells showed multiple FA sites, 
apparent as discrete streaks, in the cell periphery where la-
mellipodia formed (Fig. 1 D, arrowheads, MDCK+GFP; and 
Video 3, top). In contrast, in Par1b-GFP–expressing cells, dis-
crete paxillin-mCherry–positive FAs were absent, and paxillin-
mCherry only appeared as a continuous ring at the cell periphery 
(Fig. 1 D, MDCK+Par1b-GFP; and Video 3, top right). In con-
trast, in Par1b-KD MDCK cells, mRFP-actin exhibited in-
creased stress fiber formation in the absence of dox (when Par1b 
is absent) compared with the control cells maintained in dox 
(Fig. 1 C, Par1b-KD; and Video 2) and more numerous and 
stronger  paxillin-mCherry–positive  FAs  that  reached  further 
into the cell interior than in the controls (Fig. 1 D, top; and 
Video  3,  bottom).  Brightfield  time-lapse  imaging  of  Par1b-
MDCK cell islands at 15-min intervals over a 6-h period showed 
contacting cells to spread and flatten at a slower rate compared 
with controls, but at later time points, they contracted again and 
balled up into tightly compacted cell clusters (Fig. 1 A, right, 
“on collagen”; and Video 6). This phenotype is consistent with 
a  scenario  in  which  the  balance  between  cell–cell  adhesion 
(which promotes compaction) and cell–matrix adhesion (which 
promotes cell spreading), is shifted toward cell–cell adhesion in 
Par1b-overexpressing cells.
but not when monolayers are maintained on substrates that pro-
mote extensive cell spreading (Michalopoulos and Pitot, 1975; 
Dunn et al., 1991; Moghe et al., 1996; Cho et al., 2006). Thus, 
hepatocytes appear to engage different ECM-signaling mecha-
nisms than do columnar epithelia to organize their intercellular 
luminal domains.
Work from our group has identified the serine/threonine 
kinase Par1b/EMK1/MARK2 as a regulator of epithelial lumina. 
Depletion of Par1b or inhibition of its function with a dominant-
negative construct prevented lumen formation in MDCK cells 
in 3D collagen cultures and the formation of BC-like lumina in 
the hepatic cell line WIFB. However, Par1b overexpression pro-
moted lateral lumina, resembling the organization of hepatic 
BC in MDCK cells, a model for columnar epithelia with an api-
cal luminal domain (Cohen et al., 2004). Although Par1 sub-
strates that mediate polarity in other systems such as during 
convergent extension, during neurite polarization and in the es-
tablishment of oocyte polarity are beginning to emerge (Matenia 
and Mandelkow, 2009), no Par1b substrates relevant for epithe-
lial lumen polarity have been identified so far. It has been pro-
posed, however, that Par1b regulates the organization of the 
epithelial lateral membrane because the active form of the ki-
nase is enriched at sites of cell–cell contact (Suzuki et al., 2004) 
and  inhibition  of  Par1b  disrupted  cell–cell  adhesion  (Böhm   
et al., 1997; Elbert et al., 2006).
In this study, we report that Par1b regulates cell spread-
ing and the actin cytoskeleton at the basal domain of MDCK 
cells, and we identify IRSp53 (insulin receptor substrate p53/58) 
as a novel Par1b substrate involved in cell adhesion signaling. 
IRSp53 connects the rho-GTPases Cdc42 and Rac1 to their 
downstream effector molecules via a Src homology domain 3 
(SH3), thus functioning as a rho-GTPase signaling platform 
(Scita et al., 2008). Overexpression of IRSp53 in most cell types 
induces extensive actin-containing cell protrusions dependent 
on Cdc42, Rac1, and their SH3 domain–containing effectors 
(Krugmann et al., 2001; Miki and Takenawa, 2002). The in-
verted BAR domain in IRSp53 has been proposed to mediate the 
membrane deformation that accompanies actin polymerization 
to allow for filopodia formation (Ahmed et al., 2010). In con-
trast, the functions of endogenous IRSp53 are less understood. 
An IRSp53 knockout mouse displayed defects in dendritic   
spine formation, a Rac1-dependent process (Sawallisch et al., 
2009). IRSp53 knockdown (KD) inhibited cytokine-induced 
membrane ruffling in cultured macrophages (Abou-Kheir et al., 
2008), and reduced cell spreading has been reported for IRSp53-
depleted NIH3T3 cells (Roy et al., 2009). In polarized MDCK 
cells, IRSp53 is localized to the lateral domain and tight junc-
tion region by interacting with the PDZ domain proteins MALS 
and Lin7 via its C-terminal PDZ-binding domain (Hori et al., 
2003). The role of IRSp53 in MDCK polarity has not been stud-
ied directly, although it was recently reported that a fusion pro-
tein between a PDZ mutant of Lin7 and IRSp53 could rescue 
the delay in tight junction formation observed in the Lin7 mu-
tant lacking the PDZ domain (Massari et al., 2009). In this 
study, we report that Par1b overexpression and depletion of its 
substrate IRSp53 both inhibit basal lamina formation in 3D cul-
tures of MDCK cells and reduced cell spreading and stress fiber 527 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
Figure 1.  Par1b inhibits cell spreading and stress fiber formation and promotes cell compaction. (A) Phase-contrast images of cell islands cultured on tissue 
culture plastic for 24 h (left) or brightfield images of a time lapse (Video 6) after cell plating on collagen I (right). Translucent holes in the 24-h Par1b (dox) 
culture representing lateral lumina. (B) Spreading on collagen I. *, P < 0.001 for differences between ±dox. Error bars indicate SEM. (C, D, and F) Still 
images from time-lapse videos 30 (C and F) or 45 min (D) after plating on collagen. (C) Brightfield and mRFP fluorescence (Videos 1 and 2) are shown. 
Arrows point to stress fibers. (D) Note the dox-dependent size difference in Par1b cells and Paxillin-mCherry (Video 3). Arrowheads point to FAs. (F) GFP 
or Par1b-GFP and mRFP actin (Video 5) are shown. Note both the difference in stress fibers (arrows) and that Par1b-GFP but not GFP localizes to the tips 
of actin bundles in lamella (arrowheads). (E) Polarized Par1b cultures 24 h after Ca
2+ switch. Phalloidin labels stress fibers at the basal domain (bottom) 
and microvilli-rich lateral lumina and apical domains in the maximum (max) projections (top; Video 6). (G) Confocal sections through collagen cysts of 
Par1b-MDCK cells (±dox; see Video 4 for full stacks). Arrowheads point to gaps in laminin. Also note that Par1b cysts are smaller than WT cysts (mean: 
23 vs. 30 cells/cyst; n = 13/17). Bars: (A–F) 10 µm; (G) 25 µm.JCB • VOLUME 192 • NUMBER 3 • 2011   528
assembly associated with cell spreading and regulates the   
assembly of the epithelial basal lamina.
Par1b phosphorylates IRSp53 in vitro and 
in vivo and promotes its 14-3-3 binding
Because none of the known Par1 substrates have been impli-
cated  in  ECM  signaling,  we  initiated  an  unbiased  substrate 
screen based on the observation that Par1 phosphorylation pro-
motes 14-3-3 binding in some of its substrates (Matenia and 
Mandelkow, 2009). We compared the 14-3-3 binding profile of 
membrane/cytoskeletal fractions prepared from MDCK cells 
overexpressing Par1b wild type (WT) to that of cells expressing 
a kinase-deficient mutant, Par1b-K49A (Elbert et al., 2006),   
referred to as Par1b-KA, and we identified IRSp53 as a phospho- 
protein enriched in the Par1b-WT sample (Fig. S2). Immuno-
blotting with IRSp53 antibodies confirmed increased IRSp53 
binding from MDCK lysates to immobilized 14-3-3 in cells 
that overexpressed Par1b in a dox-regulated manner (Fig. 2 A, 
control Par1b pair). On the other hand, dox-regulated Par1b KD 
(Fig. 2 A, control Par1b-KD pair) revealed reduced IRSp53 
Polarized  Par1b-MDCK  cells  organize  with  a  hepatic 
polarity phenotype in which the luminal domain interrupts the 
lateral domain of neighboring cells rather than being established   
at the apex (Fig. 1 A, Par1b, dox, “on plastic”). We noticed 
that Par1b-MDCK with lateral lumina (Fig. 1 E, max projection 
dox) lacked stress fibers at the basal domain (Fig. 1 E, dox; 
and Video 7, top). Thus, defects in cell–matrix signaling were 
apparent not only in freshly plated cells but also in polarized 
Par1b monolayers.
When cultured in a 3D collagen I matrix, Par1b-MDCK 
cells not only formed multiple lumina rather then the central 
cavity observed in control cells but also exhibited disrupted 
laminin staining at the cyst circumference (Fig. 1 G; Fig. S1; 
and Video 4, top), suggesting defects in basal lamina formation. 
Cyst patches lacking laminin frequently showed inverted apical 
surface staining (Fig. 1 G; Fig. S1; and Video 4, top), a pheno-
type previously reported in MDCK cysts expressing dominant-
negative Rac1 (O’Brien et al., 2001). We conclude that Par1b 
not only functions at the lateral domain to regulate cell–cell   
adhesion but is also involved in actin organization and FA   
Figure 2.  Par1b promotes IRSp53 phosphorylation and 14-3-3 binding. (A) IRSp53 in total lysates from Par1b and Par1b-KD cells (1/10 input) and from 
lysate fractions adsorbed on immobilized 14-3-3 and competitively eluted. Arrows show a decrease in IRSp53 mobility in the Par1b lysates. (B) In vitro 
kinase assays of recombinant IRSp53 with Par1b-WT or Par1b-KA followed by -phosphatase (+) or mock (m) treatment and subsequent binding to immo-
bilized 14-3-3. (top) 1/10 of IRSp53 input is shown. (middle) IB is shown, with IRSp53 competitively eluted from 14-3-3 resin. (bottom) Autorad is shown, 
with [
32P]ATP-Par1b–phosphorylated IRSp53. (C) IRSp53-HA or IRSp53SH3-HA cells transduced with control, Par1b-WT, or Par1b-KA adenovirus. IB of 
1/10 Par1b, IB of HA input, and phospho-serine after HA IP are shown. (D) IRSp53-HA immunoprecipitated from [
32P]orthophosphate-labeled (autorad) 
and unlabeled (IB, IRSp53-HA) Par1b-KD cells. Par1b IB shows dox-dependent depletion of the two Par1b splice variants.529 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
As in assays with the isolated proteins, IRSp53S366A and   
IRSp53A4 were not phosphorylated by Par1b in whole cell   
lysates, although IRSp53S453-5A was, indicating that residue 
S366 is phosphorylated by Par1b, whereas the S453/4/5 phos-
phorylation occurs either via a Par1b-dependent kinase or is   
regulated by a Par1b-dependent serine phosphatase (Fig. 3 E).   
In addition, we ruled out that serines S117 and S148, present in 
two predicted low stringency 14-3-3 binding motifs in the IRSp53 
N-terminal domain (Mackie and Aitken, 2005), are phosphory-
lated by Par1b (Fig. 3 E).
Thus, our combined approaches allowed us to identify 
S366 on IRSp53 as a direct Par1b substrate and the serine clus-
ter S453-455 as a target of a Par1b-dependent kinase or phos-
phatase. IRSp53 and Par1b did not form stable complexes in cell 
lysates (unpublished data), suggesting that IRSp53 phosphory-
lation either does not take place within a Par1b-containing scaf-
folding complex but, rather, in a kiss and run fashion or occurs 
within the detergent insoluble cytoskeletal fraction that is un-
available for coimmunoprecipitation (co-IP) analysis.
We next determined whether the Par1b-dependent phos-
phorylation sites S366 and S453/454/545 are required for 14-3-3 
binding of IRSp53. The 14-3-3 binding efficiency of the IRSp53 
mutants S366A, S453-5A, and A4 corresponded to the extent of 
their in vitro Par1b phosphorylation: IRSp53-S366A showed re-
duced 14-3-3 binding compared with the WT protein, whereas the 
A4 mutant did not bind 14-3-3 at all in this direct binding assay 
(Fig. 3 F, top, lanes 1–4). Similar results were obtained when re-
combinant WT, S366A, and A4 IRSp53 proteins were expressed in 
MDCK cells and the lysates incubated with immobilized 14-3-3 
(Fig. 3 G). The S453-5A mutation also reduced 14-3-3 binding of 
IRSp53 when isolated from MDCK lysates, whereas the S117A 
and S148A mutations were without effect (Fig. 3 G). Lastly, we 
coimmunoprecipitated recombinant IRSp53-WT but not IRSp53-
A4 with recombinant 14-3-3 from MDCK lysates (Fig. 3 H).   
A phosphomimetic aspartate mutant, IRSp53-D4, was also unable 
to interact with 14-3-3 in either assay (Fig. 3 H and not depicted). 
This is similar to other cases of 14-3-3 binding where phospho-
mimetics were ineffective (Johnson et al., 2010). Together, these 
data indicate that Par1b-mediated phosphorylation of IRSp53 is 
directly responsible for its 14-3-3 binding in MDCK cells.
While  preparing  this  manuscript,  Robens  et  al.  (2010)  
reported residues T340 and T360 in IRSp53 as essential for 
IRSp53–14-3-3  interactions  in  Cos-7  cell  lysates.  However, 
when expressed in MDCK cells, a T360A IRSp53 mutant inter-
acted with 14-3-3 as efficiently as it did the WT protein (Fig. 3 G), 
suggesting that cell type–specific kinase activities might generate 
several distinct 14-3-3 binding sites centered around the SH3 
domain of IRSp53. Alternatively, the different sites might re-
cruit different 14-3-3 isoforms. However, we found that Par1b-
phosphorylated IRSp53 interacts with all three 14-3-3 isoforms 
we tested: , , and  (Fig. S3).
IRSp53 depletion in MDCK cells  
mimics aspects of the Par1b 
overexpression phenotype
To determine whether IRSp53 is a Par1b substrate involved 
in MDCK cell polarization and lumen organization, we first 
binding to 14-3-3 in Par1b-depleted MDCK cells. We also no-
ticed a small but reproducible reduction in IRSp53 mobility 
upon Par1b overexpression, which is consistent with putative 
Par1b-dependent phosphorylation of IRSp53 (Fig. 2 A, arrow). 
Indeed, expression of Par1b-WT but not of Par1b-KA induced 
serine phosphorylation in recombinant IRSp53 and in a mutant 
of IRSp53 lacking the SH3 domain (Fig. 2 C). In contrast, Par1b 
depletion reduced the incorporation of [
32P]orthophosphate into 
IRSp53 by 50% (by 70 and 40% in two separate experiments; 
Fig. 2 D). Importantly, recombinant IRSp53 was phosphory-
lated by Par1b in vitro (Fig. 2 B, [
32P]ATP) and bound to 14-3-3 
in a Par1b phosphorylation–dependent manner (Fig. 2 B, 14-3-3). 
14-3-3 binding was abolished upon -phosphatase treatment.
Par1b mediates phosphorylation on the 
IRSp53 SH3 domain flanking serines S366 
and S453/4/5
In vitro kinase assays using fragments of IRSp53 as substrates 
and subsequent in vitro mutagenesis of serines in candidate 14-3-3 
binding motifs present in the Par1b-phosphorylated C-terminal 
IRSp53 fragment (i.e., S325, S365, S366, S453-5, S492, and 
S511; not depicted) revealed S366 as the main Par1b phosphory-
lation site in IRSp53 (Fig. 3, A [IRSp53 domain organization] 
and B). In contrast, the serine cluster S453,454,455 emerged as 
the major Par1b-dependent IRSp53 site when we probed IRSp53 
mutants immunoprecipitated from cell lysates with a phospho-
serine antibody (Fig. 3 C). Mutation of all four serines to alanines 
(IRSp53A4) completely abolished Par1b-mediated phosphory-
lation both in vitro and in vivo (Fig. 3, B and C). Thus, we con-
ducted  most  of  our  subsequent  functional  studies  comparing 
IRSp53-WT with the IRSp53-A4 mutant. The discrepancy be-
tween the Par1b-dependent in vitro and in vivo phosphorylation 
sites raised the question whether Par1b indeed phosphorylates 
IRSp53 in cells or, rather, activates an IRSp53 kinase in vivo.   
Although there are currently no biochemical approaches to directly 
measure phosphorylation events in intact cells, we adapted a pre-
viously developed strategy (Blethrow et al., 2008) that allowed us 
to assess whether Par1b phosphorylates IRSp53 after cells had 
been detergent permeabilized, a prerequisite for the entry of ATP 
analogues. We expressed in MDCK cells an engineered Par1b   
kinase, Par1b-ATP* with an enlarged ATP-binding pocket, to 
identify specific kinase substrates by offering the bulky ATPS 
analogue N
6-benzyl-ATP[
35S] that can only be used by the re-
combinant kinase but not by endogenous kinases also present in 
the lysate. To validate the approach, we first established that the 
“gatekeeper-modified”  kinase  Par1b-ATP*  but  not  Par1b-WT 
transferred [
35S]thio phosphate from N
6-benzyl-ATP[
35S] onto 
recombinant full-length IRSp53 when the ATPS analogue was 
used in in vitro kinase assays with recombinant proteins. As with 
the C-terminal fragment, the S366A but not the S453-5A substi-
tution  abolished  the  specific  in  vitro  phosphorylation  of  full-
length  IRSp53  (Fig.  3  D).  Importantly,  Par1b-ATP*  but  not 
unmodified Par1b also transferred [
35S]thio phosphate from   
N
6-benzyl-ATP[
35S] onto full-length IRSp53 when the ATPS 
analogue was added to whole cell lysates prepared from cells ex-
pressing Par1b-ATP* and the IRSp53 proteins, indicating that 
Par1b directly phosphorylates IRSp53 in this context (Fig. 3 E). JCB • VOLUME 192 • NUMBER 3 • 2011   530
Figure 3.  Par1 phosphorylation on S366 and Par1b-depedendent S453/4/5 phosphorylation promote 14-3-3 binding of IRSp53. (A) Diagram of Par1b-
dependent phosphorylation sites in IRSp53. (B) In vitro kinase assays with WT and Par1b-KA using [
32P]ATP and IRSp53-CT (WT and point mutants) 
as substrates. (C) IRSp53-HA–transfected cells (WT, A4, and S453-5A) were transduced with control (c) or Par1b virus, and the HA IPs were probed for 
P-serine and subsequently for HA. (D) In vitro kinase assays with WT and Par1b-ATP* using [
35S]benzyl-ATPS and full-length IRSp53 WT and mutants as 
substrates. Autoradiographs/Coomassie stain of IRSp53. (E) Triton X-100 lysates of cells coexpressing Par1b-WT or Par1b-ATP* and WT IRSp53-Myc or 
IRSp53 mutants were incubated with [
35S]benzyl-ATPS. Autoradiographs and IB for IRSp53-Myc and Par1b. (F) Recombinant WT IRSp53 and mutant 
proteins subjected to in vitro kinase assays with Par1b-WT or Par1b-KA were affinity isolated on 14-3-3 beads and competitively eluted (top). IRSp53 
input (middle) and Par1b levels (bottom) are also shown. (G) 14-3-3 binding of IRSp53 proteins from cell lysates. Note the lower expression of the S117A 
sample accounts for the weaker signal in the bound fraction. The graph shows SEM from six experiments (three experiments for S117A/S148A). (H) Co-IP 
of 14-3-3-HA with IRSp53-Myc proteins from cell lysates.
analyzed the phenotype of MDCK clones that feature dox- 
regulated depletion of IRSp53 by expressing an IRSp53-directed 
shRNAmir under an inducible promoter (Fig. 4 A). The target 
region was based on a previously published IRSp53-directed 
RNAi sequence (Shi et al., 2005). IRSp53 depletion yielded the 
hepatic polarity phenotype characteristic of Par1b-overexpressing 531 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
IRSp53-A4 rescues the Par1b 
overexpression phenotypes
Thus far, our data suggest that Par1b-mediated phosphorylation 
of IRSp53 inhibits its function and is responsible for some of 
the Par1b-induced morphological and polarity phenotypes in 
MDCK cells. To test this hypothesis, we asked whether ex-
pression of IRSp53-WT or its phosphorylation-deficient mutant 
IRSp53-A4  could  alleviate  Par1b-induced  spreading  defects 
and antagonize lateral lumen polarity.
We  first  determined  whether  KD-resistant  IRSp53-WT 
and IRSp53-A4 were able to rescue the IRSp53-KD–induced 
spreading defect. We generated stable cell lines expressing near-
endogenous levels of recombinant IRSp53 constructs under the 
weak thymidine kinase promoter (Fig. S5 C). Into those clones, 
we transiently transfected the shIRSp53mir-cDNA to reduce 
endogenous IRSp53 levels. Real-time PCR with canine-specific 
primers indicated a KD efficiency between 43 and 65% for dif-
ferent clones (Fig. S5 B), resulting in a more modest decrease of 
spreading compared with the stable IRSp53-KD clones (Fig. 4 A, 
immunoblot  [IB];  compare  parental  mock  with  IRSp53-KD 
mRNA in Fig. S5 B). All five IRSp53-A4 clones and all four 
IRSp53-WT clones rescued the spreading defects and, to vary-
ing degrees, showed increased spreading compared with the   
parental cells (Fig. 5 A). None of the clones displayed a lateral 
polarity phenotype (unpublished data). These findings verify 
that the IRSp53 shRNAmir phenotype is not caused by an off-
target effect.
Next,  we  transduced  the  IRSp53-WT  and  IRSp53-A4 
clones with recombinant adenoviruses expressing either l-Cat 
(controls) or Par1b. The Par1b-induced spreading defect was 
rescued in six of the eight tested IRSp53-A4 clones, i.e., the 
mean cell diameter of the Par1b-transduced clones was with 
statistical significance different from that of parental Par1b-
transduced cells but not from parental cells transduced with   
the control virus. In contrast, only one of the five IRSp53-WT 
clones showed a statistically significant increase in mean cell 
diameter over the parental cells when transduced with Par1b virus 
(Fig. 5 B). Likewise, when we cotransfected two IRSp53-WT and 
two IRSp53-A4 clones with Par1b-GFP and paxillin-mCherry, 
we observed extensive FAs only in the IRSp53-A4 but not the 
WT clones (Fig. 5 C and Video 9, bottom, WT clone #1 and A4 
clone #5). Thus, we conclude that IRSp53-A4 is more efficient 
than IRSp53-WT in antagonizing the Par1b-induced spreading 
defect in MDCK cells.
When we tested the effect of IRSp53-WT and IRSp53-A4 
on Par1b-induced lateral lumen formation, we observed simi-
larly that the A4 mutant was far more effective than IRSp53-
WT in reverting the lateral lumen polarity phenotype, yielding 
apical luminal domains (Fig. 5 D). Importantly, an SH3-deficient 
IRSp53 mutant was without any effect, indicating that the 
IRSp53 effector domain is important for the rescue. In these   
experiments, we used our Par1b cell line and transiently trans-
fected  the  cells  with  recombinant  IRSp53  constructs.  Using 
Par1b virus transduction in the aforementioned IRSp53 clones 
yielded similar results (unpublished data). Furthermore, we de-
termined that reducing IRSp53 levels and expressing low levels 
of recombinant Par1b promoted lateral lumina in a synergistic 
MDCK monolayers (Fig. 4 C, top, “max”; compare with Fig. 1 E) 
although in fewer cells (38% of cells vs. 70% in Par1b clones 
24 h after polarity was initiated) and not as robustly because the 
number of IRSp53-depleted cells with hepatic-type polarity de-
creased to 21% 48 h after the initiation of cell–cell adhesion 
(see Fig. 7). In 3D collagen cultures, IRSp53-KD caused multi-
ple lumina as seen in Par1b-MDCK cells (Fig. 4 G; Fig. S1; and 
Video 4, bottom). These data suggest that, although not suffi-
cient to account for the Par1b polarity phenotype, inhibition of 
IRSp53 signaling contributes to Par1b-induced hepatic-type   
lumen organization.
The localization of both Par1b and IRSp53 to the lateral 
membrane in polarized MDCK cells and to peripheral actin struc-
tures in freshly plated cells (Fig. 1 F and not depicted; Böhm   
et al., 1997; Hori et al., 2003) suggested that IRSp53 could either 
regulate cell–cell or cell–ECM signaling downstream of Par1b.
Because we had previously implicated cell–cell adhe-
sion as a target of Par1b signaling (Cohen et al., 2007), we 
first  tested  whether  IRSp53  depletion  altered  E-cadherin– 
mediated adhesion and tight junction formation in Ca
2+ switch 
assays (Gonzalez-Mariscal et al., 1990). As shown in Fig. S4   
(A and B), IRSp53 depletion did not alter the kinetics of   
E-cadherin recruitment or its incorporation into the cortical actin 
cytoskeleton. Although the formation of tight junctions, as indi-
cated by ZO-1 recruitment to cell–cell contacts sites, appeared 
to be delayed 3 h after Ca switch in IRSp53 depleted cells, it 
was comparable with control conditions at the 8- and 24-h time 
points (Fig. S4 C).
However,  we  found  that  IRSp53  depletion  reduced   
spreading of freshly plated MDCK cells on collagen I substrate 
and prevented the complete circumferential lamella skirt and 
circumferential stress fibers seen in control cells between 30 
and 120 min after plating (Fig. 4 D and Video 7) similarly to our 
observations with Par1b overexpression (Fig. 1, B and C, Par1b). 
Likewise, paxillin-mCherry–positive FAs were largely absent 
in IRSp53-depleted cells (Fig. 4 F; and Video 9, top). A quanti-
tative analysis presented in Fig. 4 E shows spreading defects in two 
inducible IRSp53-shRNAmir clones up to 120 min upon plat-
ing. Spreading defects were similar in cultures maintained   
in low-Ca
2+ medium, indicating that they are independent of   
cell–cell adhesion (Fig. 4 E, Spinner Modified Eagle’s medium 
[SMEM]). Consistent with IRSp53 regulating cell spreading 
but not cell–cell adhesion, we also observed an extreme com-
paction of freshly plated IRSp53-depleted cell islands when im-
aged over a 6-h period (Fig. 4 B [4–6 h]; and Video 10). Again, 
this phenomenon mimicked the effect of Par1b overexpression 
(compare with Fig. 1 A, “on collagen”; Video 6). In addition, we 
found that, like Par1b-MDCK cells, IRSp53-depleted cells with 
lateral lumina lacked stress fibers at the basal domain (compare 
Fig. 5 C; and Video 7, bottom; with Fig. 1 E; and Video 7, top). 
Lastly, the IRSp53-KD cysts featured drastically reduced and 
fragmented laminin staining, indicating defects in basal lamina 
assembly (Fig. 4 G; Fig. S1; and Video 4, bottom) Collectively, 
our findings indicate that Par1b and IRSp53 have opposing roles 
in cell–matrix signaling that governs cell spreading, FA forma-
tion, and the organization of the actin cytoskeleton at the basal 
surface and basement membrane organization.JCB • VOLUME 192 • NUMBER 3 • 2011   532
Figure 4.  IRSp53 depletion mimics aspects of the Par1b overexpression phenotype. (A) Dox-inducible IRSp53 depletion is shown. (B) Brightfield time lapse 
of IRSp53-KD cell islands on collagen I (Video 10). (C) Polarized cultures 24 h after Ca
2+ switch. Phalloidin labels stress fibers at the basal domain (bottom) 
and microvilli-rich lateral lumina and apical domains in the maximum (max) projections (top; see Video 7). (D and F) Still images from time-lapse videos 
taken 30 min after plating on collagen. (D) Brightfield and mRFP fluorescence (Video 8). (F) Paxillin-mCherry (Video 9, top) is shown. Arrowheads point 
to FAs. (E) Spreading of two IRSp53-KD clones on collagen I in DME and SMEM; all differences between ±dox are significant with P < 0.001. Error bars 
indicate SEM. (G) Confocal section through collagen cysts (see Video 4 for full stacks) annotated as in Fig. 1 G. IRSp53KD cysts are smaller than control 
cysts (14 vs. 25 cells/cyst; n = 31). Bars: (B–D and F) 10 µm; (G) 25 µm.533 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
Figure 5.  A nonphosphorylatable IRSp53 mutant rescues the Par1b phenotype. (A) Parental MDCK cells and five clones expressing RNAi-resistant   
IRSp53-A4 and four clones of IRSp53-WT cells were transiently transfected with mock or IRSp53shmir cDNA and analyzed for cell spreading 2 h after plat-
ing. (B) 2-h spreading in parental cells, eight IRSp53AA, and five IRSp53WT clones that were transduced with control or Par1b adenovirus. (C) Paxillin-mCherry in 
WT clone #1 and A4 clone #5 expressing Par1b-GFP 30 min after plating on collagen I. Arrowheads point to FAs (Video 9, bottom). (D) Par1b-MDCK cells 
transfected with mock or IRSp53 cDNAs (WT, A4, DD, and SH3) were quantitatively analyzed for lumen polarity as described in Materials and methods. 
*, P < 0.0001 with difference to parental or mock-transfected cells. Error bars indicate SEM. Bars: (A and B) 30 µm; (C and D) 10 µm.JCB • VOLUME 192 • NUMBER 3 • 2011   534
involves still additional factors that account for the robustness 
of the lumen phenotype once polarity is fully established. We 
conclude that myosin II and IRSp53 inhibition by Par1b con-
tribute to lumen organization in a synergistic fashion, most likely 
operating in different signaling pathways.
Par1b-mediated 14-3-3 binding inhibits 
protein recruitment to the IRSp53  
C-terminal domain
Our observation that IRSp53’s role in lumen polarity down-
stream of Par1b is dependent on its SH3 domain (Fig. 5 D) 
prompted us to test whether Par1b-induced 14-3-3 binding inter-
feres with the recruitment of IRSp53 effector proteins to its 
SH3 domain. Indeed, recombinant IRSp53-A4 coimmunopre-
cipitated slightly more recombinant WAVE2 than IRSp53-WT. 
This difference was even more pronounced in the presence of 
recombinant Par1b (Fig. 8 A), suggesting that Par1b phosphory-
lation interferes with WAVE–IRSp53 binding. In contrast, no 
difference was apparent in the interaction of WT and A4-IRSp53 
with activated Cdc42 (Q61L; Fig. 8 B). We performed these   
experiments in 293 cells because coexpression of WAVE2 and 
IRSp53 caused WAVE2 aggregates in MDCK cells.
We next assessed the binding of proteins from lysates of 
[
35S]Met  metabolically  labeled  cells  to  immobilized  GST-
IRSp53-CT, the IRSp53 fragment that includes the SH3 domain 
and the Par1b phosphorylation sites (Fig. 2 A). When in vitro 
phosphorylated by Par1b and subsequently incubated with re-
combinant  14-3-3,  GST-IRSp53-CT  recruited  at  least  six  of   
the specifically binding proteins to a lesser extent than GST-
IRSp53-CT that had been mock phosphorylated and that did not 
bind 14-3-3 (Fig. 8, C and D). Although the differences were 
modest (between 25 and 30%), they were expected to be so be-
cause only a fraction of IRSp53-CT becomes phosphorylated 
and binds 14-3-3 in vitro (Fig. 8 D).
Together, these data indicate that Par1b phosphorylation 
inhibits the recruitment of IRSp53-binding proteins to the   
SH3 domain and potentially other domains within the IRSp53   
C terminus. The inhibition of multiple protein interactions is 
consistent with a steric hindrance caused by 14-3-3 binding 
rather than the regulation of a specific protein–protein inter-
action by phosphorylation.
Discussion
The role of Par1b in epithelial cells has been associated with   
its localization and activity at the lateral membrane and, spe-
cifically, with E-cadherin function. In this study, we show that 
Par1b also regulates cell spreading, FA formation, the organiza-
tion of the actin cytoskeleton at the basal surface, and laminin 
deposition, consistent with a role in cell–matrix signaling. We 
identified IRSp53 as a Par1b substrate mediating its role in basal 
actin organization in epithelial cells. This conclusion is based 
on the following findings: (a) Par1b directly phosphorylates 
IRSp53 in vitro and in cell lysates at S366 and, in addition, stimu-
lates IRSp53 phosphorylation at S453/4/5 indirectly in vivo, 
whereas Par1b depletion reduces IRSp53 phosphorylation in 
intact cells. (b) IRSp53 KD mimics all of the observed effects of 
fashion  (Fig.  6).  A  “leaky”  IRSp53KD  clone  showed  an   
50% reduction of IRSp53 in +dox (Fig. 6 A) and exhibited 
few lateral lumina when transduced with a control virus (Fig. 6 B, 
IRSp53KD+dox/control virus). Par1b adenovirus transduction 
at levels that caused few lateral lumina in parental MDCK cells 
(Fig. 6 B, parental+dox/Par1b virus), however, featured close   
to 45% lateral lumen polarity in IRSp53KD+dox monolayers 
(Fig. 6 B, IRSp53KD+dox/Par1b virus).
Collectively, the Par1b phosphorylation-deficient IRSp53 
mutant A4 was able to antagonize the effect of Par1b over-
expression in cell spreading and lumen formation in MDCK 
cells while IRSp53-WT was, in each case, either less effective 
or ineffective in overcoming the Par1b phenotype. We conclude 
that Par1b phosphorylation inhibits IRSp53 to yield cytoskeletal 
defects that underlie the Par1b phenotype.
Par1b-induced inhibition of IRSp53 and 
myosin promote hepatic-type lumen polarity 
in a synergistic fashion
We had previously reported that Par1b-mediated inhibition of 
myosin II contributes to the hepatic polarity phenotype in 
Par1b-MDCK cells (Cohen et al., 2007). The myosin II–specific 
inhibitor blebbistatin (BB) promoted lateral lumina during po-
larization, but only transiently. To determine whether myosin II 
and IRSp53 function synergistically to yield the Par1b polarity 
phenotype, we compared the effect of IRSp53 depletion on   
lumen organization 24 and 48 h after the initiation of cell–cell 
contacts  either  in  the  presence  or  absence  of  BB. Although   
neither BB nor IRSp53 depletion alone matched the extent of 
lateral lumen formation found in Par1b-MDCK cells, in combi-
nation, they caused 66% of the cells to adopt hepatic-type polar-
ity at the 24-h time point, although significantly fewer lumina 
were observed at 48 h (Fig. 7). Thus, Par1b signaling presumably 
Figure 6.  Decreased IRSp53 and increased Par1b levels have a syner-
gistic effect on lateral lumen formation. (A) IRSp53 expression in parental 
cells and an IRSp53KD clone in ±dox and after adenovirus transduction 
as indicated. (B) Lateral lumen polarity analyzed as described in Materials 
and methods. Error bars indicate SEM.535 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
the concentration of low-affinity binding sites. 14-3-3 molecules 
are obligate dimers that interact with two binding sites in either 
the same protein or by scaffolding two molecules (Johnson 
et al., 2010). (b) Recruitment of 14-3-3 masks the SH3 domain 
for binding of effector proteins that mediate actin polymerization 
downstream of rho-GTPases. WT-IRSp53, but not the phos-
phorylation-resistant mutant A4, showed reduced interaction 
with WAVE2 when Par1b was coexpressed. The inhibitory   
effect is not limited to WAVE2, as six unidentified proteins 
showed reduced in vitro binding to the IRSp53 C-terminal 
domain when preceded by Par1b-dependent 14-3-3 recruit-
ment. Our model is similar to that recently proposed by Robens 
et al. (2010), who identified T340/T360 close to the Par1b site 
at S366, as important for 14-3-3 binding and inhibitory for   
effector recruitment to IRSp53 in Cos7 cells. Although the au-
thors did not identify the responsible kinase, it is conceivable 
that  in  different  cell  types,  distinct  kinases  regulate  14-3-3-
binding in the vicinity of the SH3 domain to inhibit IRSp53’s 
scaffolding function.
Par1b overexpression on cell substrate signaling. (c) Impor-
tantly,  a  Par1b  phosphorylation–deficient  IRSp53  mutant   
rescued  the  spreading  defect  of  Par1b-overexpressing  cells, 
whereas expression of WT-IRSp53 was ineffective. These data 
are consistent with a scenario in which Par1b phosphorylation 
inhibits IRSp53 function. Fig. 9 presents our model for the 
mechanism of this inhibitory effect: (a) Par1b phosphorylation 
creates 14-3-3 binding sites proximal and distal to the IRSp53 
SH3 effector domain. Both Par1b phosphorylation sites con-
tributed to effective binding of IRSp53 from MDCK lysates   
to 14-3-3 and are located within sequences that conform with   
low stringency to a class I 14-3-3 binding consensus motif accord-
ing to Scan Site analysis (http://scansite.mit.edu/motifscan_seq 
.phtml). Cooperative binding to multiple low-stringency sites 
has  been  shown  for  some  14-3-3  interactions  (Dougherty   
and Morrison, 2004). It is noteworthy in this respect that the 
N-terminal helical domain (aa 1–260) of IRSp53 mediates its 
dimerization and might thereby contribute to 14-3-3 binding as 
previously suggested (Mackie and Aitken, 2005) by increasing 
Figure 7.  IRSp53 and myosin II function synergistically to regulate epithelial lumen polarity. IRSp53KD (dox) and control (+dox) subjected to Ca
2+ 
switch assays for 24 and 48 h in the presence or absence of 50 µM BB. Lumen polarity was quantified as described in Materials and methods. Statistically 
significant difference is shown with P < 0.0001 (*). Images represent the 24-h time point. Error bars indicate SEM. Bars, 10 µm.JCB • VOLUME 192 • NUMBER 3 • 2011   536
proteins  have  been  identified  in  this  pathway,  including  the 
Cdc42 effectors Mena and N-WASP, the Rac1 effector WAVE, 
racGEF Tiam1, and mDia1. During the late spreading phase, a 
poorly understood switch from Rac1 to rhoA activity occurs 
that might be triggered by an increase in membrane tension as 
cells extend their surface area (Huveneers and Danen, 2009). 
Aberrant lamella in spreading of IRSp53-depleted cells suggest 
a role for IRSp53 in Rac1/Cdc42 signaling; whether lack of   
IRSp53  regulates  outside-in  and  inside-out  cell–matrix 
interactions in MDCK cells. On one hand, IRSp53 directs cyto-
skeletal dynamics and FA formation in response to integrin en-
gagement on collagen substrates; on the other hand, it participates 
in the formation of the epithelial basal lamina. In the early cell 
spreading phase, integrin engagement activates the FAK–Src 
kinase complex that in turn stimulates Cdc42 and Rac1 activity 
while rhoA is inhibited. Several known IRSp53-interacting   
Figure 8.  Par1b phosphorylation inhibits the recruitment of WAVE2 and other IRSp53-binding proteins to its C-terminal, SH3-containing domain.  
(A and B) WAVE2 co-IPs with IRSp53 in 293 cells expressing WAVE2-GFP, Myc-tagged IRSp53 constructs (WT, A4, or IRSp53 317–521; CT), and Par1b 
where indicated. 1/10 of the lysate was analyzed for WAVE and Par1b expression. (B) Data are from three experiments with and without recombinant 
Par1b and three experiments without recombinant Par1b only. Error bars indicate SEM. (C) Cdc42Q61L co-IPs with IRSp53-Myc constructs from 293 cells. 
Arrows indicate Cdc42, and asterisks indicate IgG H and L chains. Data are representative of three experiments. (D–F) GST-IRSp53CT was subjected to 
Par1b phosphorylation, immobilized on glutathione and incubated with 14-3-3 as indicated. (D) Experimental schematic is shown. (E) Binding of proteins 
from [
35S]Met/Cys-labeled 293 lysates to immobilized IRSp53CT was analyzed by Coomassie and autoradiography. Arrows indicate specific bands that 
are reduced in the Par1b sample. Asterisk indicates cellular 14-3-3, with one out of two identical results represented. (F) 14-3-3 binding to IRSp53CT was 
analyzed by IB, and IRSp53-CT levels by Ponceau red stain are shown.537 IRSp53 as Par1b substrate in ECM signaling • Cohen et al.
junctions, was dispensable for Rac1 activation and heterotypic 
E-cadherin engagement and clustering (Kraemer et al., 2007). 
Thus, IRSp53-independent mechanisms of Rac1–WAVE activa-
tion operate, or can at least compensate, for IRSp53 depletion at 
the lateral membrane.
In summary, we identified IRSp53 as the first Par1b sub-
strate that contributes to its role in lumen polarity. The fact that 
IRSp53 works downstream of Par1b in cell spreading and lat-
eral lumen polarity, whereas only Par1b but not IRSp53 regu-
lates cell–cell adhesion, suggests that Par1b function in lumen 
formation involves cell–ECM signaling.
Materials and methods
Cell lines and culture
For cell spreading analysis, cells were trypsinized and plated at 25,000 
cells/cm
2  on  10  µg/cm
2  rat  tail  collagen  I  (BD)–coated  coverslips  or   
MatTek chambers (for live cell analysis) for 30, 60, 90, and 120 min or for 
up to 6 h. For synchronized cell polarization analysis in Figs. 1 E, 4 C,   
5 D, 6, 7, and S4, Ca
2+ switch assays were performed as described previ-
ously (Cohen et al., 2004). Transduction with recombinant Par1b adeno-
virus (Figs. 2 A, 3 C, and 6 B; Cohen et al., 2004) was in serum-free 
SMEM for 1 h with 1 plaque-forming unit/cell. mRFP-actin, Par1b-GFP, 
paxillin-mCherry, and tagged IRSp53 cDNAs were transfected by nucleo-
fection (Lonza) as previously described (Cohen et al., 2004). All experi-
ments  in  which  the  effect  of  Par1b  was  assessed  (except  for  Par1b 
radial stress fibers is simply the consequence of early spread-
ing  defects  or  whether  IRSp53  also  regulates  rhoA  directly   
cannot be resolved at the moment, although the reduced dia-
metrical stress fibers might indicate a direct effect of IRSp53 on 
rhoA activity in polarized cells. Actin dynamics at the leading 
edge of lamellae also govern the clustering and positioning of 
activated 1-integrins (Galbraith et al., 2007) that in turn could 
account for the role of IRSp53 in FA formation. As in early 
spreading,  activation  of  Rac1  and  concomitant  inhibition  of 
rhoA underlie the assembly of laminin into a basal lamina in 
MDCK cysts (Yu et al., 2005, 2008), and thus, similar IRSp53-
signaling  platforms  could  operate  to  regulate  spreading  and 
basal lamina assembly.
Although  prominently  associated  with  the  region  of   
cell–cell  contact,  no  defects  in  adherens  junction  formation 
were apparent in IRSp53-depleted MDCK cells. This was some-
what surprising, given that depletion of WAVE2 or the WAVE- 
stabilizing proteins Abi1 and HSP300, which can form a complex 
with IRSp53 to mediate Arp2/3-dependent actin polymerization 
downstream of Rac1, caused severe defects in E-cadherin re-
cruitment to cell–cell contact sites in polarizing cells (Yamazaki 
et al., 2007). The scenario is reminiscent of that described for 
Tiam1, which despite being recruited to nascent E-cadherin 
Figure 9.  Model for Par1b regulation of IRSp53 in epithelial lumen formation. Activated Rac1 or Cdc42 recruit Rho-GTPase effector proteins such as Mena, 
WAVE, mDia, and Eps8 involved in microfilament organization to the IRSp53 SH3 domain. Phosphorylation of S366 by Par1b and Par1b stimulation of S434-5 
phosphorylation by an unidentified kinase recruits 14-3-3 proteins that interfere with WAVE2 binding and the recruitment of other proteins that interact with 
the IRSp53 C-terminal domain. Par1b overexpression inhibits IRSp53-dependent actin dynamics that regulate cell–ECM signaling and result in altered lumen 
polarity in MDCK cells. In other cell types, such as Cos7, unidentified kinases inhibit IRSp53 function by creating 14-3-3 binding sites on T340/T360.JCB • VOLUME 192 • NUMBER 3 • 2011   538
polyclonal (ab15697; Abcam), and mouse monoclonal (#612674; BD), 
anti–phospho-serine (#600-401-261; Rockland), and anti-laminin (L9393; 
Sigma-Aldrich).
Immunolabeling techniques and IF analysis
For immunofluorescence analysis, cells were fixed in 2% paraformalde-
hyde at 37°C, permeabilized with 0.2% Triton X-100, and blocked with 
1% BSA. Antibody incubation was performed in PBS/1% BSA. Secondary 
antibodies used were coupled to Alexa Fluor 488, Cy3, or Alexa Fluor 
647. In addition, rhodamin-phalloidin was used. Coverslips were mounted 
in  nonhardening  medium  containing  glycerol/2.5%  DABCO.  3D  cysts 
were incubated with a laminin antibody for 4 h at 37°C before fixation 
and labeled with primary and secondary antibodies at 4°C overnight. 
Confocal microscopy was performed with a microscope (TCS SP5; Leica) 
using either an HCX Plan Apo CS 63.0× 1.40 NA oil or 40.0× 1.25 NA 
oil objective. Individual confocal x-y or x-z sections, or where indicated,   
x-y-z or x-z-y projections generated with LAS AF software (Leica) are pre-
sented. The phase-contrast images in Fig. 1 A were acquired on a DMIL 
microscope (Leica) with a 20× NA 0.3 objective equipped with a digital 
camera (Leica). All image figures were composed with Photoshop (Adobe). 
Brightness  was  adjusted  using  the  “Brightness”  function  on  the  entire   
image. For quantitative IB analysis, we probed all blots either with 
125I– 
protein A (Fig. 2, A and C; and Fig. 3 C) or DyLight 680/800–coupled 
secondary antibodies (all other IBs) and analyzed them in a laser scanner 
(Typhoon [Amersham] or FLA-9000 [Fujifilm]). Cell lysis in the experiments 
for Figs. 2 and 3 was performed in RIPA buffer (20 mM Tris-/HCl, pH 7.5, 
150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.25% deoxycholate, and pro-
tease and phosphatase inhibitors) as previously described (Elbert et al., 
2006). For Fig. 2 D, cells were labeled with 0.2 mCi/ml [
32P]Na phos-
phate for 90 min before cell lysis and IP with HA antibodies. For the experi-
ments in Fig. 8, cells were lysed in a Triton X-100 buffer (20 mM Tris-HCl, 
pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 10% glycerol, and 
protease and phosphatase inhibitors). GST-IRSp53CT and 14-3-3 binding 
to immobilized IRSp53-CT occurred in the same buffer. Metabolic labeling 
occurred with 0.1 mCi/ml [
35S] translabel (PerkinElmer) in Met/Cys-free 
DME overnight.
Quantification of lumen polarity and cell spreading
Quantification of cells exhibiting lateral lumina and of cell spreading was 
obtained from 40× confocal images of fixed cells, which were labeled for 
gp135  and  ZO-1  or  rhodamine-phalloidin,  respectively.  Lateral  lumina 
were defined by gp135 accumulation between neighboring cells flanked 
by a circumferential ring of ZO-1. Data in Fig. 5 D are from two experi-
ments with five images (150 cells/image), and data in Figs. 6 and 7 are 
from  three  experiments  with  five  images  (150  cells/image)  per  time 
point. For cell spreading, the longest cell diameter, including lamellipodia 
extending beyond the cell body, was measured using ImageJ (National   
Institutes of Health). Data are from three experiments with five images 
(50 cells per image). Standard errors are presented, and significance 
was determined in two-tailed Student’s t tests.
Live cell microscopy
Live cell imaging was performed starting 30–60 min after plating on colla-
gen I with a microscope (TCS SP5) equipped with a motorized x-y stage for 
multiple position finding (Leica) and with an 8,000-Hz resonant scanner 
(lenses: HCX Plan Apo CS 63.0× NA 1.40 oil or 40.0× NA 1.25 oil). 
Cells were imaged on collagen I–coated MaTek chambers at 37°C in a 
CO2-enriched atmosphere in recoding medium (DME without Phenol red, 
10% FCS, 3.7 mg/ml NaHCO3, and 25 mM Hepes, pH 7.4; line mean, 
32–128; frame mean, 1). Single confocal planes (pinhole setting 1 or 2 AU) 
and a 488-nm line of an Argon laser and 594-nm laser for GFP, mRFP, and 
brightfield were used. Image sequences were processed with ImageJ and 
QuickTime.
14-3-3 affinity chromatography
About  360  million  TAP-tagged  Par1b  or  Par1b-K49A–expressing  cells 
were homogenized by nitrogen cavitation and 8 ml postnuclear super-
natant  separated  into  cytosolic  and  membrane/cytoskeletal  fraction  by 
centrifugation at 150,000 g for 90 min. The pellet was solubilized in RIPA 
buffer containing 1% NP-40 and 0.5% deoxycholate (protease inhibitors: 
2 mM AEBSF and 10 µg/ml each leupeptin, pepstatin, and antipain; phos-
phatase inhibitors: 2 mM orthovanadate, 10 mM NaF, 10 mM glycero-
phosphate,  and  5  mM  Na-pyophosphate)  and  by  passing  three  times 
through a 30-G needle. The solubilized fraction (cleared by a 45-min spin 
at 17,000 g) was incubated overnight with 20 µl immobilized 14-3-3 and 
adenovirus–transduced and Par1b-GFP–transfected cells) were conducted 
in  a  Par1b-MDCK  cell  line  expressing  C-terminal  Myc-tagged  canine 
EMK1/Par1b under a dox-regulated promoter 10-fold over endogenous 
levels as previously described (Cohen et al., 2004). For control conditions, 
expression of the recombinant protein was repressed by 1 µg/ml dox. 
IRSp53 shRNAmir and Par1b shRNAmir inducible cell lines were gener-
ated from the MDCK Tet-Off cell line T23 (provided by K. Mostov, Univer-
sity of California, San Francisco, San Francisco, CA). Induction by dox 
withdrawal occurred for 4 d. IRSp53-shRNAmir cells were induced in the 
presence of 50 µM enoxacin to enhance the RNAi response (Shan et al., 
2008) for 4 d. Controls were maintained in the presence of dox but also 
enoxacin treated. Dox-inducible HA-IRSp53 and HA-IRSp53SH3 MDCK 
Tet-Off cell lines were provided by J. Casanova (University of Virginia, Char-
lottesville, VA; Shi et al., 2005) and induced for 24 h by dox removal. Stable 
MDCK cell lines constitutively expressing IRSp53-HA3 and IRSp53A4-HA3 
were generated from T23-MDCK cells. For Figs. 2 C, 5 B, and 6, adeno-
viruses encoding  l-Cat (chloramphenicol acetyl transferase), Par1b, and   
kinase-dead Par1b-K49A (Par1b-KA) were transduced as previously de-
scribed (Cohen et al., 2007). For 3D culture, Par1b and IRSp53KD cells 
were cultured in ±dox for 2 d before seeding in 3D collagen I cultures and 
grown for 6 d as previously described (Cohen and Müsch, 2003).
cDNA constructs and recombinant proteins
Par1b-shmir and IRSp53-shmir oligos were generated by PCR amplification 
as previously described (Sun et al., 2006) and cloned into the pTRE2   
vector. The following target sequences for both mRNAs were previously 
described and validated (Cohen et al., 2004; Shi et al., 2005): Par1b,   
5-AAGAGGTAGCTGTGAAGATCAT-3; IRSp53, 5-CGACACTTGTATG-
AAGATGTAA-3. mRFP-actin cDNA was provided by A. Barth (Stanford 
University, Palo Alto, CA), and Par1b-GFP was generated from the long 
splice variant of canine Par1b (Cohen et al., 2004) cloned into pEGFP-N1. 
The paxillin-mCherry plasmid was provided by S. Hanks (Vanderbilt Uni-
versity, Nashville, TN). cDNA encoding Cdc42Q61L-HA3 was provided 
by R. Cerione (Cornell University, Ithaca, NY). WAVE-GFP cDNA was pro-
vided by D. Cox (Albert-Einstein College of Medicine, The Bronx, NY). 
cDNA of human Myc-tagged IRSp53 (in pRK5; Krugmann et al., 2001) 
was provided by A. Hall (Memorial Sloan-Kettering, New York, NY), and 
HA-IRSp53 and SH3-HA-IRSp53 (in pTRE2; Shi et al., 2005) were pro-
vided by J. Casanova. Both cDNAs were used as templates for site-directed 
mutagenesis to introduce the Ser/Thr-Ala mutations using the QuickChange 
Mutagenesis kit (Agilent Technologies). All mutant constructs were verified 
by sequencing. The human IRSp53-WT and IRSp53-A4 cDNAs were also 
cloned into pKH3 (Mattingly et al., 1994) for triple-HA tagging and subse-
quently exchanged for the luciferase cDNA in the pRL-TK vector (Promega) 
to yield IRSp53-HA3 under the thymidine kinase promoter. cDNAs encod-
ing GST-tagged IRSp53 aa 1–178, aa 1–317, aa 180–317, aa 180–
521, and aa 319–521 (Krugmann et al., 2001) were provided by A. Hall, 
and GST-tagged proteins were prepared from BL21 cells according to   
standard procedures. Full-length IRSp53 was cloned into pT7TEV-HMBP3 
(provided by E. Yakubovskaya, Stony Brook University, Stony Brook, NY; 
Yakubovskaya et al., 2010), purified as His-tagged MBP fusion protein 
from bacteria by affinity chromatography on Ni-agarose, followed by 
TEV protease cleavage to release the untagged IRSp53 moiety. His-tagged 
recombinant TEV was readsorbed on Ni beads. 14-3-3 cDNA (I.M.A.G.E. 
clone 5100237) was cloned into pGEX4T-1, purified from bacteria accord-
ing to standard procedures, and covalently coupled to Affi15 gel (Bio-Rad 
Laboratories) according to the manufacturer’s instructions at a concentra-
tion of 20 mg/ml gel. Recombinant 14-3-3 and His-14-3-3 were pur-
chased from ProSpec.
Real-time PCR
Primer  pairs  5-CCTGCCCAGACGGCCGGTAC-3/5-CTGCTCACAG-
CCCGTGCTCCG-3  and  5-GGGAAATCGTGCGTGACATTAAG-3/5-TGT-
GTTGGCGTACAGGTCTTTG-3  specific  for  canine  IRSp53  mRNA  and 
actin, respectively, were used to amplify 100-bp fragments from total   
reverse-transcribed MDCK cDNA using Sypro Green Mix (Thermo Fisher 
Scientific) in a realplex Mastercycler (Eppendorf).
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provided by G. Ojakian, Downstate Medical Center, State University of 
New York, Brooklyn, NY), rat monoclonal ZO-1 (Millipore), E-cadherin 
monoclonal clone rr1 (provided by the Developmental Studies Hybrid-
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eluted with 2× 100 µl 0.5 mM R18 peptide (Wang et al., 1999). Protein 
bands excised from colloidal Coomassie-stained gels were identified by 
nano liquid chromatography/tandem mass spectrometry peptide sequenc-
ing by ProtTech, Inc. IRSp53 was identified on the basis of four peptides: 
(ALAGVTYAAK, YSDKELQYIDAISNK, SFHNELLTQLEQK, and EGDLITLL-
VPEAR). 14-3-3-binding of recombinant IRSp53 from unfractionated RIPA 
lysates occurred in a similar manner. For recombinant binding assays,   
5 µg recombinant IRSp53 was subjected to kinase assays with Par1b or 
Par1b-KA immunoisolated from 1 mg cell lysate in the presence of 1 mM 
ATP and subsequently incubated with 5 µl immobilized 14-3-3.
Par1b kinase assays
In vitro kinase assays with immunoprecipitated Par1b and recombinant 
IRSp53 substrate were conducted as previously described for Dvl (Elbert   
et al., 2006), with the difference that TAP-tagged Par1b and Par1b-KA and 
TAP-tagged Par1b with an enlarged ATP-binding pocket (Par1b *ATP) were 
affinity isolated on IgG Sepharose and that the ATP analogue N
6-benzyl-
ATP[
35S] rather than [
32P]ATP was used for the assay in Fig. 3 D. The   
details of this approach were based on previous experiments (Blethrow   
et al., 2004, 2008). For the kinase assays in cell lysates, TAP-Par1b and 
TAP-Par1b*ATP  cell  lines  were  transiently  transfected  with  Myc-IRSp53   
constructs, and a Triton X-100 lysate (concentration of 5–10 mg/ml) was 
incubated with 1 mM GTP and 100,000 cpm N
6-benzyl-ATP[
35S] for 1 h 
at 30°C.
Online supplemental material
Fig. S1 shows that 3D collagen cysts of Par1b-overexpressing and IRSp53-
depleted cells have multiple lumen, inverted apical surfaces, and disrupted 
laminin at the basal domain. Fig. S2 shows that IRSp53 becomes enriched 
in the 14-3-3 binding fraction in Par1b-overexpressing cells. Fig. S3 shows 
that Par1b phosphorylation stimulates IRSp53 binding to 13-4-4, -, and 
- Fig. S4 shows that IRSp53 depletion does not compromise E-cadherin 
recruitment to cell–cell adhesion sites or its association with microfilaments 
in  Ca
2+  switch  assays  Fig.  S5  shows  expression  of  shRNAmir-resistant 
IRSp53  in  IRSp53-depleted  cells.  Video  1  shows  spreading  and  actin 
dynamics in Par1b-MDCK cells cultured in either +dox or dox and ex-
pressing  mRFP-actin.  Video  2  shows  spreading  and  actin  dynamics  in 
Par1b-KD-MDCK cells. Video 3 shows paxillin dynamics in Par1b and 
Par1b-KD MDCK cells expressing paxillin-mCherry. Video 4 shows con-
focal x-y series through collagen I cysts of Par1b-MDCK cells and IRSp53-
KD cells cultured in +dox and dox. Video 5 shows actin dynamics of 
T23 (control)-MDCK cells expressing either GFP or Par1b-GFP and mRFP 
actin.  Video  6  shows  cell  spreading  and  compaction  in  Par1b-MDCK 
monolayers cultured in +dox or dox. Video 7 shows phalloidin staining 
in Par1b-MDCK cells ±dox and in IRSp53KD cells ±dox. Video 8 shows 
spreading and actin dynamics in IRSp53KD-MDCK cells cultured in +dox 
or dox and expressing mRFP-actin. Video 9 shows paxillin dynamics in 
IRSp53-KD cells cultured in +dox or dox and expressing paxillin-mCherry 
and rescue with IRSp53 WT and IRSp53-4A. Video 10 shows cell spread-
ing and compaction in IRSp53-KD-MDCK monolayers cultured in +dox 
or dox. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201007002/DC1.
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